Augmedix, Inc. (AUGX)
NASDAQ: AUGX · IEX Real-Time Price · USD
0.918
-0.081 (-8.14%)
At close: May 31, 2024, 4:00 PM
0.950
+0.032 (3.47%)
After-hours: May 31, 2024, 7:59 PM EDT
Augmedix Market Cap
Augmedix has a market cap or net worth of $44.96 million as of May 31, 2024. Its market cap has decreased by -71.22% in one year.
Market Cap
44.96M
Enterprise Value
33.22M
1-Year Change
-71.22%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since March 31, 2021, Augmedix's market cap has decreased from $134.30M to $44.96M, a decrease of -66.52%. That is a compound annual growth rate of -29.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 45.00M | -8.16% |
May 30, 2024 | 49.00M | -12.19% |
May 29, 2024 | 55.80M | 3.53% |
May 28, 2024 | 53.90M | -3.41% |
May 24, 2024 | 55.80M | 1.82% |
May 23, 2024 | 54.80M | -4.36% |
May 22, 2024 | 57.30M | -2.55% |
May 21, 2024 | 58.80M | 3.52% |
May 20, 2024 | 56.80M | -4.22% |
May 17, 2024 | 59.30M | -1.50% |
May 16, 2024 | 60.20M | 3.26% |
May 15, 2024 | 58.30M | 3.92% |
May 14, 2024 | 56.10M | -51.05% |
May 13, 2024 | 114.60M | 5.72% |
May 10, 2024 | 108.40M | -10.86% |
May 9, 2024 | 121.60M | -4.40% |
May 8, 2024 | 127.20M | -4.07% |
May 7, 2024 | 132.60M | 0.76% |
May 6, 2024 | 131.60M | -0.38% |
May 3, 2024 | 132.10M | 1.93% |
May 2, 2024 | 129.60M | 5.11% |
May 1, 2024 | 123.30M | -6.66% |
Apr 30, 2024 | 132.10M | -4.21% |
Apr 29, 2024 | 137.90M | -0.72% |
Apr 26, 2024 | 138.90M | 2.13% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Kronos Bio | 47.47M |
Lucid Diagnostics | 46.59M |
Envoy Medical | 46.45M |
Gain Therapeutics | 46.03M |
Eagle Pharmaceuticals | 45.06M |
Incannex Healthcare | 44.92M |
Aligos Therapeutics | 44.26M |
Aadi Bioscience | 44.20M |